Mont Vernon, NH, United States of America

Melissa A Ashlock


Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2002-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Melissa A. Ashlock

Introduction

Melissa A. Ashlock is a prominent inventor based in Mont Vernon, NH (US). She has made significant contributions to the field of genetics, particularly in relation to Niemann-Pick type C disease. With a total of two patents to her name, her work has the potential to impact the diagnosis and detection of this rare genetic disorder.

Latest Patents

Ashlock's latest patents focus on a gene for type C Niemann-Pick disease (NP-C). The patents disclose the amino acid sequence of the encoded peptide, which is crucial for understanding the disease. Applications stemming from this invention include the detection of NP-C carriers and the diagnosis of individuals suffering from NP-C. Additionally, the murine ortholog of the human gene is also disclosed, further enhancing the understanding of this condition.

Career Highlights

Melissa A. Ashlock is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her role at this esteemed institution allows her to engage in groundbreaking research that contributes to public health and medical advancements.

Collaborations

Throughout her career, Ashlock has collaborated with notable colleagues, including Eugene D. Carstea and Danilo A. Tagle. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in genetics.

Conclusion

Melissa A. Ashlock's contributions to the field of genetics, particularly in relation to Niemann-Pick type C disease, highlight her role as an influential inventor. Her patents and work at the National Institutes of Health underscore the importance of innovation in addressing complex health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…